Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

445
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
445
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

848
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
848
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

180
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
180
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

439
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
439
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

867
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
867
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

150
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
150

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Not All Flares Are Equal: Stratifying Risk During Asthma/COPD Overlap Exacerbations.

Respirology (Carlton, Vic.)·2026
Same author

Guselkumab for checkpoint inhibitor-exacerbated psoriasis in a patient with metastatic melanoma.

Clinical and experimental dermatology·2026
Same author

Glycoengineered Recombinant Alpha1-Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma-Derived Protein.

Biotechnology and bioengineering·2026
Same author

Synchronous Late‑Onset Allograft Papillary RCC in Paired Kidney Recipients: A 15‑Year Post‑Transplant Report.

Clinical transplantation·2026
Same author

GOLD stage 1 COPD pharmacotherapy: big questions, few answers.

The European respiratory journal·2026
Same author

Electroencephalography, behavioural observations, bleed-out and temperature at the point of application in cattle receiving DTS: Diathermic Syncope® at 160-200 kJ.

Veterinary and animal science·2026

Related Experiment Video

Updated: Nov 19, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

627

Alpha-1 antitrypsin deficiency-associated panniculitis.

Alessandro N Franciosi1, James Ralph2, Naoimh J O'Farrell3

  • 1Department of Medicine, Beaumont Hospital, Dublin, Ireland; Irish Centre for Genetic Lung Disease, Royal College of Surgeons in Ireland, Dublin, Ireland.

Journal of the American Academy of Dermatology
|January 31, 2021
PubMed
Summary

Alpha-1 antitrypsin deficiency (AATD) is a rare cause of panniculitis. Intravenous AAT augmentation is effective, while glucocorticoids are ineffective for AATD-associated panniculitis.

Keywords:
AATDalpha-1 antitrypsinaugmentationdapsoneneutrophilicpanniculitis

More Related Videos

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.5K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.7K

Related Experiment Videos

Last Updated: Nov 19, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

627
Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.5K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.7K

Area of Science:

  • Medical Science
  • Genetics
  • Dermatology

Background:

  • Panniculitis is a rare, potentially fatal condition linked to alpha-1 antitrypsin deficiency (AATD).
  • Limited evidence exists for managing AATD-associated panniculitis, primarily from case reports.

Purpose of the Study:

  • To define the characteristics of AATD-associated panniculitis.
  • To review diagnostic approaches.
  • To assess therapeutic interventions for AATD-panniculitis.

Main Methods:

  • Comprehensive literature search of MEDLINE, PubMed, and reference lists.
  • Included articles and abstracts from 1970 to 2020.
  • Focused on keywords: panniculitis, alpha-1 antitrypsin deficiency, and Weber-Christian disease.

Main Results:

  • 117 cases of AATD-panniculitis identified; AATD found in 15% of biopsy-proven panniculitis cases.
  • Systemic steroids showed no clinical response.
  • Dapsone had frequent remission failures, but intravenous AAT augmentation therapy was generally effective.

Conclusions:

  • AATD may be underdiagnosed in panniculitis patients.
  • Panniculitis with systemic illness carries a high mortality risk.
  • Intravenous AAT augmentation is the most effective treatment; glucocorticoids are ineffective.